Startups raise $1.5bn; Microsoft to invest $80bn in data centres; CRISPR shows safety
July saw Israeli AI firms secure $1.5bn, Microsoft announced an $80bn AI data‑centre spend, and a CRISPR stem‑cell transplant trial reported safety in AML patients.
Compiled automatically from the sources listed below and checked against Hyperuranios' own capital and research data. Every figure here traces to a linked source. Factual errors reported to the contact address are corrected in the article and noted here.
Artificial Intelligence
In July Israeli startups announced 29 funding rounds that together raised about $1.518 billion, highlighting investor preference for enterprise AI infrastructure over consumer‑facing models. Notable deals included Glow’s $180 million round at a $1.2 billion valuation, Onyx’s $113 million raise, Neo’s $100 million financing, and Xsight Labs’ $300 million round at a $2.8 billion valuation for networking chips. Other significant raises were groundcover’s $100 million for AI observability, Enigma’s $71 million seed to build foundation models for intelligent robots, and a series of security‑focused startups such as Mate Security and Bloom Security. The breadth of the month’s funding underscored AI’s role as a foundational technology across sectors [1].